Effect of Probiotic Lozenges on Halitosis in Patients With Chronic Periodontitis

NCT02789436 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2016-06-03

No results posted yet for this study

Summary

The purpose of this study is to determine whether Lactobacillus reuteri-containing lozenges (Prodentis) are effective in treatment of halitosis in patients with chronic periodontitis.

Conditions

  • Halitosis

Interventions

DRUG

L. reuteri Prodentis® lozenges

Twice daily, for 28 days

OTHER

Placebo lozenges

Twice daily, for 28 days

Sponsors & Collaborators

  • BioGaia AB

    collaborator INDUSTRY
  • University of Zagreb

    lead OTHER

Principal Investigators

  • Darije Plančak, Professor · University of Zagreb

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2016-09-30

Countries

  • Croatia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02789436 on ClinicalTrials.gov